Moreover, depending on CD47, the modified exosomes could target oncogenic Kirsten rat sarcoma viral oncogene homolog (KRAS) via micropinocytosis, which would suppress pancreatic cancer progression and increase the survival rate in mice models (14). The gene discussed is KRAS; the disease is familial pancreatic carcinoma.